IDEXX Laboratories Inc (IDXX) Stock Analysis
$IDXX · HEALTHCARE · DIAGNOSTICS & RESEARCH
IDEXX Laboratories (IDXX), a DIAGNOSTICS & RESEARCH company, has a market capitalization of about $53.37B and trades at 38.9x trailing earnings.
Price
$677.36
Market cap
$53.37B
P/E ratio
38.9x
Dividend yield
—
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
How StockWorthy values IDXX
StockWorthy forecasts IDEXX Laboratories Inc's revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from IDXX's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.
Related stocks
See IDXX's Fair Value
Create a free account to view IDEXX Laboratories Inc's base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.